150 related articles for article (PubMed ID: 16028695)
1. Gene therapy for hypertension: antisense inhibition of the renin-angiotensin system.
Phillips MI; Kimura B
Methods Mol Med; 2005; 108():363-79. PubMed ID: 16028695
[TBL] [Abstract][Full Text] [Related]
2. Antisense therapeutics for hypertension: targeting the renin-angiotensin system.
Phillips MI; Kimura B
Methods Mol Med; 2005; 106():51-68. PubMed ID: 15375312
[No Abstract] [Full Text] [Related]
3. Antisense inhibition and adeno-associated viral vector delivery for reducing hypertension.
Phillips MI
Hypertension; 1997 Jan; 29(1 Pt 2):177-87. PubMed ID: 9039099
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy for hypertension: sense and antisense strategies.
Phillips MI
Expert Opin Biol Ther; 2001 Jul; 1(4):655-62. PubMed ID: 11727501
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin I-converting enzyme antisense gene therapy causes permanent antihypertensive effects in the SHR.
Wang H; Reaves PY; Gardon ML; Keene K; Goldberg DS; Gelband CH; Katovich MJ; Raizada MK
Hypertension; 2000 Jan; 35(1 Pt 2):202-8. PubMed ID: 10642298
[TBL] [Abstract][Full Text] [Related]
6. Angiotensinogen and AT(1) antisense inhibition of osteopontin translation in rat proximal tubular cells.
Ricardo SD; Franzoni DF; Roesener CD; Crisman JM; Diamond JR
Am J Physiol Renal Physiol; 2000 May; 278(5):F708-16. PubMed ID: 10807582
[TBL] [Abstract][Full Text] [Related]
7. Antisense inhibition of hypertension: a new strategy for renin-angiotensin candidate genes.
Phillips MI; Wielbo D; Gyurko R
Kidney Int; 1994 Dec; 46(6):1554-6. PubMed ID: 7700004
[TBL] [Abstract][Full Text] [Related]
8. Antisense inhibition of AT1 receptor mRNA and angiotensinogen mRNA in the brain of spontaneously hypertensive rats reduces hypertension of neurogenic origin.
Gyurko R; Wielbo D; Phillips MI
Regul Pept; 1993 Dec; 49(2):167-74. PubMed ID: 8134617
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy for hypertension: antisense inhibition with adeno-associated viral vector delivery targeting angiotensin II type 1-receptor messenger ribonucleic acid.
Phillips MI
Am J Cardiol; 1998 Nov; 82(10A):60S-62S. PubMed ID: 9860363
[No Abstract] [Full Text] [Related]
10. Sustained inhibition of angiotensin I-converting enzyme (ACE) expression and long-term antihypertensive action by virally mediated delivery of ACE antisense cDNA.
Wang H; Katovich MJ; Gelband CH; Reaves PY; Phillips MI; Raizada MK
Circ Res; 1999 Oct; 85(7):614-22. PubMed ID: 10506486
[TBL] [Abstract][Full Text] [Related]
11. Reduction of cold-induced hypertension by antisense oligodeoxynucleotides to angiotensinogen mRNA and AT1-receptor mRNA in brain and blood.
Peng JF; Kimura B; Fregly MJ; Phillips MI
Hypertension; 1998 Jun; 31(6):1317-23. PubMed ID: 9622148
[TBL] [Abstract][Full Text] [Related]
12. Reversal of hypertension by angiotensin II type 1 receptor antisense gene therapy in the adult SHR.
Katovich MJ; Gelband CH; Reaves P; Wang HW; Raizada MK
Am J Physiol; 1999 Sep; 277(3):H1260-4. PubMed ID: 10484448
[TBL] [Abstract][Full Text] [Related]
13. Antisense inhibition of brain renin-angiotensin system decreased blood pressure in chronic 2-kidney, 1 clip hypertensive rats.
Kagiyama S; Varela A; Phillips MI; Galli SM
Hypertension; 2001 Feb; 37(2 Pt 2):371-5. PubMed ID: 11230302
[TBL] [Abstract][Full Text] [Related]
14. Antisense oligonucleotides targeting angiotensinogen: insights from animal studies.
Wu CH; Wang Y; Ma M; Mullick AE; Crooke RM; Graham MJ; Daugherty A; Lu HS
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30530571
[TBL] [Abstract][Full Text] [Related]
15. Transient decrease in high blood pressure by in vivo transfer of antisense oligodeoxynucleotides against rat angiotensinogen.
Tomita N; Morishita R; Higaki J; Aoki M; Nakamura Y; Mikami H; Fukamizu A; Murakami K; Kaneda Y; Ogihara T
Hypertension; 1995 Jul; 26(1):131-6. PubMed ID: 7541778
[TBL] [Abstract][Full Text] [Related]
16. The potential role of antisense oligodeoxynucleotide therapy for cardiovascular disease.
Phillips MI; Galli SM; Mehta JL
Drugs; 2000 Aug; 60(2):239-48. PubMed ID: 10983731
[TBL] [Abstract][Full Text] [Related]
17. Chronic control of high blood pressure in the spontaneously hypertensive rat by delivery of angiotensin type 1 receptor antisense.
Iyer SN; Lu D; Katovich MJ; Raizada MK
Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9960-5. PubMed ID: 8790439
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of hypertension and heart hypertrophy by adeno-associated virus delivering angiotensinogen antisense.
Kimura B; Mohuczy D; Tang X; Phillips MI
Hypertension; 2001 Feb; 37(2 Pt 2):376-80. PubMed ID: 11230303
[TBL] [Abstract][Full Text] [Related]
19. Somatic gene therapy for hypertension.
Phillips MI
Braz J Med Biol Res; 2000 Jun; 33(6):715-21. PubMed ID: 10829100
[TBL] [Abstract][Full Text] [Related]
20. Genetic targeting of the renin-angiotensin system for long-term control of hypertension.
Metcalfe BL; Raizada M; Katovich MJ
Curr Hypertens Rep; 2002 Feb; 4(1):25-31. PubMed ID: 11790288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
